Challenges in Evaluation and Management of Children with Myocardial Bridging

Nurdan Erol1

  • 1Pediatric Clinics, Zeynep Kamil Gynecology and Pediatrics Training and Research Hospital, Health Sciences University, Uskudar/Istanbul, Turkey, nurdaneroltr61@gmail.com.

Cardiology
|February 25, 2021
PubMed

Insights

Myocardial bridging (MB) is a congenital heart anomaly where coronary arteries run through heart muscle. While often benign, MB can cause serious cardiac issues and sudden death, necessitating further research into pediatric cases.

Area of Science:

  • Cardiology
  • Congenital Heart Disease
  • Vascular Biology

Background:

  • Myocardial bridging (MB) is a congenital anomaly involving coronary arteries tunneling within the myocardium.
  • Despite being often considered benign, MB is increasingly linked to significant cardiac events, including sudden cardiac death.
  • Pediatric MB literature is sparse, often relying on adult data for clinical understanding.

Purpose of the Study:

  • To compile and compare existing literature on myocardial bridging in both adult and pediatric populations.
  • To discuss clinical presentations, diagnostic approaches, and treatment strategies for MB.
  • To address knowledge gaps and emerging questions regarding pediatric myocardial bridging.

Main Methods:

  • Comprehensive literature review of adult and pediatric myocardial bridging cases.
  • Comparative analysis of clinical data, diagnostic findings, and treatment outcomes between age groups.
  • Synthesis of current understanding and identification of areas requiring further investigation.

Main Results:

  • Myocardial bridging, though congenital, often manifests symptomatically in adulthood.
  • Significant cardiac problems and sudden cardiac deaths are associated with MB, challenging its "benign" classification.
  • Existing pediatric data is limited, necessitating extrapolation from adult studies.

Conclusions:

  • Myocardial bridging requires careful clinical evaluation, especially given its potential for severe cardiac events.
  • Further research is crucial to better understand and manage pediatric myocardial bridging.
  • A unified approach to diagnosis and treatment, considering both adult and pediatric data, is needed.

Related Concept Videos

Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
127
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
145
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
161
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
147
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
109
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
102